Aiforia closes a deal with a private diagnostic laboratory in Italy
recent articles
Using Aiforia Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST Aiforia Technologies Plc has signed...
Proscia announces webinar Inside Concentriq: The Product Behind the Top KLAS Score April 28, 2026 | 11am ET | 45 minutes REGISTER NOW Digital Pathology Built for Real-World...
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for...
Lunit: AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor microenvironment not captured by conventional methods, and enable integrated analysis to...
Indica Labs: Learn about Indica Labs’ ability to deliver AI-driven CDx Advancing Precision Medicine Through Pathology and AI-Powered CDx with Indica Labs Date: 5 May 2026 Time: 8:00 PDT | 11:00 EDT | 16:00...































